Virginia Translational Research Diagnostics / ACCRF / /
Country
United Kingdom / / /
Event
Person Communication and Meetings / Employment Change / FDA Phase / /
Facility
University of Virginia / University of Gothenburg / Massachusetts General Hospital / Models Biobanking University of Virginia MD Anderson NIDCR Xenograft University of Virginia Development Johns Hopkins Dana-Farber Mass / University of Pittsburgh / M.D. Anderson Cancer Center / Wellcome Trust Sanger Institute / Sanger Institute / Anderson University of Virginia DNA Rearrangements Sanger CGH Sahlgrenska Academy / Brown University / Women’s Hospital / Johns Hopkins University / DanaFarber Cancer Institute / University of Virginia Mass / Model UCSF Characterization University of Virginia Basic Research DNA Sequencing Sanger Institute / University of California / National Institute of Dental / /
IndustryTerm
open and efficient infrastructure / protein products / pharmaceutical investigators / technology platforms / pharmaceutical firms / /
MedicalCondition
another cancer / common cancers / Advanced Disease / rare diseases / excess tumor / rare cancers / fresh tumor / human tumor / ACC tumors / non-ACC tumors / best cancer / neck cancer / implanted human tumors / cancers / tumor / cancer / tumors / disease / adenoid cystic carcinoma / salivary gland cancers / varied and complex disease / Rare Tumors / Metastatic/Recurrent Disease / /
MedicalTreatment
surgery / surgical treatment / /
Organization
Harvard Medical School / National Cancer Institute / UCLA / University of California / National Institute of Health / Wellcome Trust Sanger Institute / NIH Chemical Genomics Center / Specimens and Models Biobanking University / Brown University / Harvard / Women’s Hospital / Johns Hopkins University / Massachusetts General Hospital / National Institute of Dental and Craniofacial Research / Sahlgrenska Academy / University of Virginia Mass / University of Virginia / University of Pittsburgh / Sanger Institute / Center for Molecular Therapeutics / Scientific Advisory Board / National Cancer Institute’s Head & Neck Steering Committee / DanaFarber Cancer Institute / Model UCSF Characterization University / Anderson University / Women's Johns Hopkins INCELL University / University of California / San Francisco / University of Virginia Development Johns Hopkins Dana-Farber Mass / Steering Committee / University of Gothenburg in Sweden / /
Person
Dana-Farber Mass / Virginia Dana-Farber / Johns Hopkins / Marnie Kaufman / Virginia Mass / /
Position
affiliated investigator / Co-Founder / forward for ACC patients / General / strong advocate / Lab Technician / leading head / /
Product
ACC / /
ProgrammingLanguage
BASIC / /
ProvinceOrState
California / Massachusetts / /
PublishedMedium
Magnetic Resonance Imaging / /
Region
South Texas / /
Technology
Genomics / Chemical Genomics / Proteomics / BIOINFORMATICS / Hybridization / high-throughput screening / Cell Signaling / Drug Screening / Human Genome / MRI / Cell Signaling Technology / drug discovery / Magnetic Resonance Imaging / Gene Expression / DNA Sequencing / /
ACCRF’S RESEARCH AGENDA (September[removed]ACCRF’s Research Agenda represents the best efforts of the best minds at the best cancer institutions in the world to find a cure for adenoid cystic carcinoma (ACC). As with m